While the three biotech penny stocks highlighted in today’s article are risky, each of these under-$5 plays has earned a Moderate or Strong Buy consensus rating from analysts – and each boasts significant upside potential attributable in large part to COVID-19. For these three compelling biotech penny stocks, CLICK HERE.
![](https://www.hotstockanalyst.com/wp-content/uploads/2020/07/2020-07-09-08_15_10-round-copper-colored-coins-photo-–-Free-Money-Image-on-Unsplash.png)